Literature DB >> 17942804

Role of inflammation in atherosclerosis.

Luigi Giusto Spagnoli1, Elena Bonanno, Giuseppe Sangiorgi, Alessandro Mauriello.   

Abstract

Inflammation plays a major role in all phases of atherosclerosis. Stable plaques are characterized by a chronic inflammatory infiltrate, whereas vulnerable and ruptured plaques are characterized by an "active" inflammation involved in the thinning of the fibrous cap, predisposing the plaque to rupture. Although a single vulnerable atherosclerotic plaque rupture may cause the event, there are many other types of plaques, several of which are vulnerable. The existence of multiple types of vulnerable plaques suggests that atherosclerosis is a diffuse inflammatory process. A current challenge is to identify morphologic and molecular markers able to discriminate stable plaques from vulnerable ones, allowing the stratification of patients at high risk for acute cardiovascular and cerebrovascular events before clinical syndromes develop. With that aim in mind, this article summarizes the natural history of atherosclerotic plaques, focusing on molecular mechanisms affecting plaque progression and serum markers correlated with plaque inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942804     DOI: 10.2967/jnumed.107.038661

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  66 in total

Review 1.  Multimodality cardiovascular molecular imaging technology.

Authors:  Matthew O'Donnell; Elliot R McVeigh; H William Strauss; Atsushi Tanaka; Brett E Bouma; Guillermo J Tearney; Michael A Guttman; Ernest V Garcia
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

2.  Early detection of C-reactive protein and von Willebrand factor levels in Malaysian patients with acute coronary syndrome.

Authors:  Wen Ni Tiong; Edmund Ui Hang Sim; Alan Yean Yip Fong; Tiong Kiam Ong
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

3.  Progress in atherosclerotic plaque imaging.

Authors:  Giulia Soloperto; Sergio Casciaro
Journal:  World J Radiol       Date:  2012-08-28

4.  Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis.

Authors:  Velidi H Rao; Vikrant Rai; Samantha Stoupa; Saravanan Subramanian; Devendra K Agrawal
Journal:  Atherosclerosis       Date:  2016-03-19       Impact factor: 5.162

Review 5.  SPECT detectors: the Anger Camera and beyond.

Authors:  Todd E Peterson; Lars R Furenlid
Journal:  Phys Med Biol       Date:  2011-08-09       Impact factor: 3.609

6.  Immune function in Amazonian horticulturalists.

Authors:  Aaron D Blackwell; Benjamin C Trumble; Ivan Maldonado Suarez; Jonathan Stieglitz; Bret Beheim; J Josh Snodgrass; Hillard Kaplan; Michael Gurven
Journal:  Ann Hum Biol       Date:  2016-06-09       Impact factor: 1.533

7.  Interleukin-17 is Not Associated with Risk of Premature Coronary Artery Disease in Iranian Turks.

Authors:  Kamal Khadem-Vatani; Morteza Bagheri; Isa Abdi Rad; Salar Mahmoudi-Nejad; Mahsa Hassan-Nejad
Journal:  Maedica (Bucur)       Date:  2020-06

8.  Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles.

Authors:  Srinivas Ayyadevara; Federico Mercanti; Xianwei Wang; Samuel G Mackintosh; Alan J Tackett; Sastry V S Prayaga; Francesco Romeo; Robert J Shmookler Reis; Jawahar L Mehta
Journal:  Hypertension       Date:  2016-03-14       Impact factor: 10.190

9.  Assessment of inactive, active and mixed atherosclerotic plaques by 18F-FDG-PET; an age group-based correlation with cardiovascular risk factors.

Authors:  Johan Wassélius; Stig Larsson; Anders Sundin; Hans Jacobsson
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-11       Impact factor: 2.357

Review 10.  Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach.

Authors:  James H O'Keefe; Maia D Carter; Carl J Lavie
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.